Several studies have shown that ceramide (CER) glucosylation contributes to drug resistance in multidrug resistant (MDR) cells, and that inhibition of glucosylceramide synthase (GCS) sensitizes cells to various drug treatments.
However, the role of GCS has not been studied in drug-sensitive cancer cells. We have previously demonstrated that the anthracycline daunorubicin (DNR) rapidly induces interphasic apoptosis through neutral sphingomyelinase mediated CER generation in human leukemic cell lines. We now report that inhibition of GCS using D,L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) or 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) protected U937 and HL-60 cells from DNR induced apoptosis. Moreover, blocking CER glucosylation did not lead to increased CER levels but to increased CER galactosylation. We also observed that pretreating cells with galactosylceramide (GalCER) significantly inhibited DNR induced apoptosis. Finally, we show that GalCER enriched lymphoblast cells (Krabbe's disease) were significantly more resistant to DNR and cytosine arabinoside (Ara-C)-induced apoptosis as compared to normal lymphoblasts, while glucosylceramide enriched cells (Gaucher's disease) were more sensitive. In conclusion, this study suggests that sphingomyelin-derived CER in itself is not a second messenger but rather a precursor of both an apoptosis second messenger (GD3) and an apoptosis "protector" (GalCER). (11) . The gist of these studies provided ample evidence that GlcCER contributed greatly to drug resistance. However, the role of GCS in drug-sensitive cells has largely been overlooked.
In this study, we elected to investigate the effect of blocking GCS in our highly drug-sensitive leukemic models. Surprisingly, we observed that by using the classic GCS inhibitors PDMP and PPMP, we completely blocked DNR and Ara-C induced apoptosis. Moreover, we demonstrate that by inhibiting the glucosylation of CER, galactosylation is increased and that this is associated with DNR and Ara-C resistance.
EXPERIMENTAL PROCEDURES
Drugs and reagents -Daunorubicin (DNR) (cerubidine Statistical analysis -Student's t test was used for statistical analysis.
. (data not shown).
RESULTS

Effect of PDMP and PPMP on DNR induced apoptosis in U937 cells-
Effect of PDMP on DNR induced CER generation-
In order to confirm the efficacy of GCS inhibition by PDMP, a dose-effect study was performed using NBD-CER. As shown in Fig. 2A , PDMP at 20 µM almost completely blocked, as expected, NBD-CER conversion to NBD-GlcCER (> 90% inhibition). Higher concentrations were cytotoxic (data not shown). Moreover, we observed that concomitant with this inhibition was a pronounced increase in NBD-GalCER generation. From these observations, it appears that NBD-CER glucosylation is compensated by NBD-CER galactosylation. However, in U937-DR cells, 20 µM PDMP also significantly decreased NBD-GlcCER levels (thought less efficiently), however, we observed little NBD-GalCER formation (Fig. 2 B) . It is noteworthy that in the parental U937 cells, the metabolism of NBD-CER to Glc-and GalCER appears comparable in the absence of PDMP, whereas in the MDR U937-, NBD-GalCER formation is very limited.
Since PDMP appeared to redirect CER metabolisation towards galactosylation, we investigated the effect of PDMP on drug enduced endogenous CER generation. Indeed, apoptosis induced by DNR in myeloid leukemia cells has been correlated with early SM-derived CER generation (for review see ref 15) . As shown in Fig. 3 , PDMP did not affect DNR induced CER generation (~20-30 % increase at 8 min). Moreover, PDMP had no significant effect on basal endogenous CER and Glc-CER levels (Fig. 3, insert) . A previous study showed modest if any effect of 75 µM PDMP on CER and GlcCER levels the drug-sensitive human carcinoma cell line KB-3-1 after 24 hrs (16). Significant decrease in Glc-CER and increase in CER has only been observed for longer time periods (72 hrs [17] to one week [18] ). These observations underline that exogenous NBD-CER is rapidly metabolized by GCS (and therefore easily blocked by PDMP) and evacuated from the cells (19) . However, the endogenous conversion of CER by GCS of our myeloid leukemic cells is not readily PDMP sensitive.
Effect of DNR on CER metabolism-Since PDMP protected U937 cells from DNR induced apoptosis but did not effect DNR induced CER generation, we investigated the effect of DNR on endogenous CER metabolism. As shown in Fig. 4 time that we previously showed that the initial phases of the execution step of apoptosis are initiated (20) . Indeed, GD3 has previously been shown to be a potent apoptotic mediator directly targeting mitochondria and disrupting mitochondrial transmembrane potential (21) (22) (23) .
Effect of GalCER on DNR induced apoptosis-In our cell model, PDMP blocked DNR induced apoptosis and prevented the metabolism of NBD-CER to NBDGlcCER while increasing the formation of NBD-GalCER ( Fig. 2A) . Furthermore, PDMP had little effect on DNR-induced SM-derived CER generation (Fig. 3) . We investigated whether PDMP and PPMP could reproduce these effects on endogenous To examine whether this increase in GalCER could present an anti-apoptotic effect, we investigated whether exogenous GalCER could influence DNR induced apoptosis. As shown in Fig. 6A and B, pretreatment of U937 cells with 5 µM GalCER presented a significant inhibition of DNR induced apoptosis. However, 10 µM GalCER alone presented cell toxicity which precluded its use (data not shown).
Experiments were also performed using psychosine (the immediate metabolite of GalCER) but no cytoprotective effect was observed (data not shown). Finally, we investigated whether sphingosine-1 phosphate could contribute to the observed cytoprotective effect of PDMP. Cells were co-incubated with 10 µM dimethylsphingosine (DMS) (an inhibitor of sphingosine kinase) and PDMP for 15
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Effect of DNR on Gaucher's and Krabbe's disease lymphocytes-Since our
observations indicated that the metabolism of CER towards GD3 is an important apoptotic pathway while the conversion of CER towards GalCER is potentially antiapoptotic, we investigated the sensitivity to both DNR and Ara-C on cells which constitutively present deficient catabolism of GlcCER or GalCER, Gaucher and Krabbe cells, respectively (24, 25) . As shown in Fig. 7 compared to four normal immortalized lymphocytic cell lines, the four Gaucher cell lines were significantly more sensitive to DNR induced apoptosis while the three Krabbe cell lines were significantly more resistant. Since basal apoptotic levels were observed to be similar, one could speculate that GlcCER and GalCER levels are only implicated in stressinduced cell signaling. Although this is highly indirect evidence, these observations underline the potential role of GalCER as an anti-apoptotic lipid.
DISCUSSION
In this study, we investigated, using DNR and Ara-C which induce rapid interphasic apoptosis at the clinically optimal concentration of 1 and 40 µM, respectively, the role of early CER metabolism (< 20 minutes) in U937 and HL-60 leukemic cells (4, 5) . The initial generation of CER has been shown to be implicated in apoptosis signaling in several human leukemia cells, as well as in a number of acid SMase deficient models (4, (26) (27) (28) . We and other have shown that only this initial CER generation but not the later delayed CER accumulation (which is at least partially fumonisin B inhibitable) is correlated with apoptosis signaling (20, 26, 29) . A close look at the literature suggests that blocking GlcCER synthesis does not necessarily lead to increased apoptosis. Indeed, okadaic acid-induced CER elevation while markedly potentiated by blocking GlcCER synthesis did not result in increased apoptosis in human CHP-100 neuroepithelioma cells (31) . Such discrepancies may be explained by different basal levels of GlcCER and GalCER. For example, HepG2
hepatoma cells displayed only a modest apoptotic response to doxorubicin treatment (32) . Since liver cells are rich in GalCER (33), one could speculate that in such cells the high GalCER levels provide a protective effect against certain effectors.
Moreover, MDR and MRP cells present elevated GalCER as well as GlcCER (34, 35) .
We propose that the relative balance (or imbalance) of basal GalCER and GlcCER levels could represent a predisposition for sensitivity or resistance to rapid interphasic SM-derived CER-mediated apoptosis. Finally, it has also been demonstrated that in MDR cells, gangliosides are important P-gp regulators perhaps through their capacity to modulate P-gp phosphorylation and that PDMP-induced ganglioside depletion plays a significant role in PDMP-mediated MDR reversal (36).
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These observations question the role of CER as an apoptotic mediator. Indeed, CER generation has also been implicated in cell proliferation of quiescent fibroblasts (37) . It would be of interest to determine if in such a model the SM-derived CER is converted to GalCER rather than GlcCER. Furthermore, one of the main arguments for linking CER to apoptosis has been the use of exogenous cell-permeable analogs.
However, we have previously demonstrated that such analogs act as stress-inducers leading to endogenous SM-derived CER (20) .
Taken together, our results show that in a rapid interphasic apoptotic model, where early SM-derived CER is rapidly converted to GD3, blocking the glucosylation of CER leads not to sensitization but rather to protection from apoptosis. The rerouting of CER metabolism towards GalCER appears to be implicated in cell death protection. Previous, studies have demonstrated that upon ceramidase stimulation, CER can be catabolized into sphingosine which, in turn, can be converted into sphingosine-1-phosphate through sphingosine-1-kinase. Sphingosine-1-phosphate has emerged as a potent regulator of apoptosis. Indeed, sphingosine-1-phosphate inhibits apoptosis induced by CER and other effectors (38, 39) . The mechanism by which sphingosine-1-phosphate interferes with CER-induced apoptotic signaling is not fully understood. However, it has been reported that sphingosine-1-phosphate inhibits CER-induced JNK stimulation and caspase activities (39, 40) . From these studies, one can speculate that sphingosine-1-kinase stimulation may contribute to DNR resistance. However, in our study we observed that the sphingosine-1-kinase inhibitor DMS did not affect of the cytoprotective effect of PDMP in DNR or Ara-C treated cells (data not shown). Moreover, we previously reported that DNR induced both CER production and apoptosis in cells derived from Farber's disease, which are genetically deficient for lysosomal ceramidase, the major component of cellular ceramidase activity (41) . Hence, although we cannot totally exclude the implication of extralysosomal ceramidases (42) , these result suggests that sphingosine 1-phosphate plays little if any role in DNR-induced apoptosis in myeloid or lymphoid cells.
Finally, our study strongly suggests that SM-derived CER in itself is not a second messenger but rather a precursor of both an apoptosis second messenger (GD3) and an apoptosis "protector" (GalCER). Furthermore, our study suggests that cells sensitivity to drug-induced apoptosis is related to the basal GalCer and GlcCER levels. Hence the balance between GalCER versus GlcCER levels may represent a novel "rheostat" which determines cell sensitivity to drug-induced apoptosis.
Further studies are ongoing in our laboratory using siRNA based technology and UDP-galactose:ceramide galactosyltransferase transfection in order to further evaluate the role of GalCER in stress-induced cell signaling and apoptosis. 
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